Document Type
Article
Publication Date
6-1-2023
Abstract
PURPOSE: Despite family history being an established risk factor for prostate cancer, the role of a broader definition of family history inclusive of not just prostate cancer but other genetically related malignancies has not been investigated in the active surveillance population. Here, we evaluate the impact of an expanded definition of family history on active surveillance outcomes.
MATERIALS AND METHODS: Patients undergoing active surveillance for prostate cancer at Massachusetts General Hospital from 1997-2019 with detailed data available on family cancer history were identified. Primary outcome was biopsy progression-free survival, and secondary outcomes were treatment-free survival, adverse pathological features at prostatectomy, and biochemical recurrence after treatment. Statistical analyses were conducted using the Kaplan-Meier method and Cox regression.
RESULTS: Among 855 evaluable patients, 300 (35.1%) patients had any family history of prostate cancer, and 95 (11.1%) had a family history of related malignancies suggestive of a hereditary cancer syndrome. Family history of prostate cancer alone was not associated with biopsy progression, whereas family history suggestive of a hereditary cancer syndrome was associated with a significantly increased risk of biopsy progression (HR 1.43, 95%CI 1.01-2.02), independent of other known clinicopathological risk factors in multivariable analysis. Similarly, family history suggestive of a hereditary cancer syndrome was associated with significantly lower treatment-free survival (HR 1.58, 95%CI 1.14-2.18) in multivariable analysis. No significant association was found between family history and adverse features on surgical pathology or biochemical recurrence.
CONCLUSIONS: An expanded family history suggestive of a hereditary cancer syndrome is an independent predictor of biopsy progression during active surveillance. Men with such a family history may still be offered active surveillance but should be counseled regarding the higher risk of disease progression.
Recommended Citation
Schneider, Adam C.; Chandrasekar, Thenappan; Bowler, Nicholas; Fogg, Ryan; Leong, Joon Yau; Gusev, Andrew; Rodgers, Linda H.; McCormick, Shelley R.; Dahl, Douglas M.; Efstathiou, Jason A.; Blute, Michael L.; Zietman, Anthony L.; Wu, Chin-Lee; Smith, Matthew R.; Van Allen, Eliezer M.; Feldman, Adam S.; and Salari, Keyan, "Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer" (2023). Department of Urology Faculty Papers. Paper 77.
https://jdc.jefferson.edu/urologyfp/77
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
PubMed ID
36951811
Language
English
Comments
This article is the author's final published version in The Journal of Urology, Volume 209, June 2023, Pg. 1112 - 1119.
The published version is available at https://doi.org/10.1097/JU.0000000000003396. Copyright © 2023 The Author(s). Published on behalf of the American Urological Association, Education and Research, Inc.